(VIANEWS) - Devon Energy (DVN), Harmony Biosciences Holdings (HRMY), The ONE Group Hospitality (STKS) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Devon Energy (DVN)
40.3% sales growth and 40.31% return on equity
Devon Energy Corporation is an independent energy company that primarily engages with the development and exploration of natural gas and oil liquids in the United States. The company has approximately 5,134 total gross wells. Devon Energy Corporation was founded in 1971. It is located in Oklahoma City.
Earnings Per Share
As for profitability, Devon Energy has a trailing twelve months EPS of $-7.12.
The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 40.31%.Dividend Yield
As maintained by Morningstar, Inc., the next dividend payment is on Jun 9, 2022, the estimated forward annual dividend rate is 5.08 and the estimated forward annual dividend yield is 8.08%.
Moving Average
Devon Energy's worth is above its 50-day moving average of $64.45 and above its 200-day moving average of $59.43.Yearly Top and Bottom Value
Devon Energy's stock is valued at $65.33 at 06:22 EST, way under its 52-week high of $79.40 and way higher than its 52-week low of $35.55.
Growth Estimates Quarters
The company's growth estimates for the present quarter and the next is 296.7% and 126.9%, respectively.2. Harmony Biosciences Holdings (HRMY)
36.2% sales growth and 31.15% return on equity
Harmony Biosciences Holdings, Inc. is a pharmaceutical company at the commercial stage that develops and markets therapies for rare neurological conditions. WAKIX, the company's drug product is used to treat excessive sleepiness among adults with narcolepsy. In February 2020, Harmony Biosciences II, Inc. was the company's name. The company changed its name from Harmony Biosciences II, Inc. to Harmony Biosciences Holdings, Inc. Harmony Biosciences Holdings, Inc. is an organization that was founded in 2017. Its headquarters are in Plymouth Meeting, Pennsylvania.
Earnings Per Share
As for profitability, Harmony Biosciences Holdings has a trailing twelve months EPS of $0.94.
PE Ratio
Harmony Biosciences Holdings has a trailing twelve months price to earnings ratio of 45.18. Meaning, the purchaser of the share is investing $45.18 for every dollar of annual earnings.
The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 31.15%.3. The ONE Group Hospitality (STKS)
10.9% sales growth and 81.48% return on equity
The ONE Group Hospitality, Inc., a company that specializes in hospitality, creates, controls, licenses, and operates restaurants and lounges around the world. The company operates via the STK, Kona Grill and ONE Hospitality divisions. It also offers turn-key food services and beverages for hotels and casinos. The company offers hospitality consulting and advisory services, as well as developing and managing restaurants, bars and rooftops. It operates restaurants under the STK, Kona Grill and other brands. It owned, operated and managed 60 restaurants as of December 31, 2020. This includes 23 STKs, 24 Kona Grills, in North America and Europe. There were also 13 F&B outlets in seven casinos and hotels in Europe and the United States. Denver, Colorado is the home of ONE Group Hospitality, Inc., which was established in 2004.
Earnings Per Share
As for profitability, The ONE Group Hospitality has a trailing twelve months EPS of $-0.44.
The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 81.48%.4. Equity Residential (EQR)
9% sales growth and 11.64% return on equity
Equity Residential believes in creating an environment where everyone can thrive. Equity Residential, a S&P 500 member, focuses on residential property acquisitions, development, and management in dynamic areas that are attractive to long-term renters. Equity Residential has invested in or owns 305 properties that include 78,568 apartments units. These properties are located in Boston and New York as well as Washington D.C. Seattle, San Francisco San Francisco, Southern California, Denver, San Francisco, San Francisco, San Francisco, San Francisco and San Francisco.
Earnings Per Share
As for profitability, Equity Residential has a trailing twelve months EPS of $1.77.
PE Ratio
Equity Residential has a trailing twelve months price to earnings ratio of 38.36. Meaning, the purchaser of the share is investing $38.36 for every dollar of annual earnings.
The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 11.64%.Sales Growth
Equity Residential's sales growth is 14.2% for the ongoing quarter and 9% for the next.
Growth Estimates Quarters
The company's growth estimates for the ongoing quarter and the next is a negative 71.3% and a negative 72.1%, respectively.5. Repligen Corporation (RGEN)
6.7% sales growth and 9.35% return on equity
Repligen Corporation is a bioprocessing technology and system company that develops, markets, and sells in North America, Europe and the Asia Pacific. The company offers Protein A binding compounds for Protein A affinitychromatography resins and products that promote cell growth. The company offers chromatography products such as OPUS prepacked chromatography columns which can be used for the purification and validation of biologicals. OPUS smaller scale columns are also used in process development screening and validation of viral clearance studies. Scale down validation and validation of chromatography processes are some of the products. The company also sells ELISA testing kits and chromatography resins, under the CaptivA name. The company also offers filtration products such as XCell Alternative Tangential Flow systems, which can be used for upstream perfusion or cell culture processing. TangenX flat sheets cassettes are used downstream in biologic drug concentrations and formulation processes. KrosFlo tangential filtration and tangential depth filtration systems. Spectra/Por process and laboratory dialysis products. SpectraFlo dynamic systems. ProConnex hollow fiber single-use. It also offers process analytics products such as slope spectroscopy under the SoloVPE and FlowVPE brands. It sells products to diagnostics, life sciences and biopharmaceutical companies, laboratory researchers, contract manufacturers, as well as contract manufacturing firms. Repligen Corporation and Navigo Proteins GmbH have collaboration agreements to create multiple affinity ligands. Repligen Corporation was founded in 1981. It is located in Waltham Massachusetts.
Earnings Per Share
As for profitability, Repligen Corporation has a trailing twelve months EPS of $2.63.
PE Ratio
Repligen Corporation has a trailing twelve months price to earnings ratio of 85.63. Meaning, the purchaser of the share is investing $85.63 for every dollar of annual earnings.
The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 9.35%.